Dec 13, 2007 by Brian LawlerTough Times for Small HIV FightersTrimeris announces another restructuring.
Dec 12, 2007 by Brian LawlerPatent Bill Is No PanaceaA new bill affecting drugmakers doesn't do enough to encourage pharma innovation.
Dec 11, 2007 by Brian LawlerIt's Hurry Up and Wait for GlaxoIt'll be years before it makes money from its two new deals, if it makes money from them at all.
Dec 10, 2007 by Brian LawlerWill the FDA Clear Cardiome?The agency prepares to debate a lead drug candidate.
Dec 10, 2007 by Brian LawlerImClone in a Giving MoodThe biopharma company settles a distracting lawsuit.
Dec 7, 2007 by Brian LawlerPain Continues as PlannedPain Therapeutics reports on a successful phase 3 trial.
Dec 7, 2007 by Brian LawlerDrugmakers Gear Up for ASHA major medical conference is just around the corner.
Dec 6, 2007 by Brian LawlerGenentech Voted DownAn FDA panel recommends against expanded use of Genentech's lead drug.
Dec 6, 2007 by Brian LawlerA Full Slate for ExelixisWhat's on tap for the drugmaker? More of what investors saw this year.
Dec 5, 2007 by Brian LawlerThe FDA Says It Needs a Pep PillDrugmakers offering new treatments might be discouraged by the agency's latest report.
Dec 4, 2007 by Brian LawlerWill Avastin Squeeze Past the FDA?Genentech tries to add an indication to the Avastin label.
Dec 4, 2007 by Brian LawlerPipeline Stocking Stuffer for BioMarinBioMarin acquires the rights to a drug candidate.
Nov 30, 2007 by Brian LawlerBiotech Bets for 2008Previewing the FDA's big decisions in the year ahead.
